Cardiac Rehabilitation Delivery Model for Low-Resource Settings: An International Council of Cardiovascular Prevention and Rehabilitation Consensus Statement

Progress in Cardiovascular Diseases

Volumn 59, Issue 3, 2016, Pages 303-322

  Grace, Sherry L ^a,b,k   Turk Adawi, Karam I ^a   Contractor, Aashish ^c,k   Atrey, Alison ^d   Campbell, Norman R C ^e   Derman, Wayne ^f   Ghisi, Gabriela L M ^a   Sarkar, Bidyut K ^g   Yeo, Tee J ^h   Lopez Jimenez, Francisco ⁱ   Buckley, John ^j,k   Hu, Dayi ^l   Sarrafzadegan, Nizal ^m  

^a YORK UNIVERSITY   (Canada)

^b TORONTO REHABILITATION INSTITUTE   (Canada)

^c Division of Critical Care   (India)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF CALGARY   (Canada)

^f UNIVERSITY OF STELLENBOSCH   (South Africa)

^g PUBLIC HEALTH FOUNDATION OF INDIA   (India)

^h NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

ⁱ MAYO CLINIC   (United States)

^j UNIVERSITY OF CHESTER   (United Kingdom)

^k International Council of Cardiovascular Prevention and Rehabilitation   (United Kingdom)

^l PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^m ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

more..

Author keywords

Cardiac rehabilitation; Community health; Delivery models; Middle income countries; Primary care

Indexed keywords

ACETYLSALICYLIC ACID; AMFEBUTAMONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYTISINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VARENICLINE;

BEHAVIOR CHANGE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COMMUNITY BASED REHABILITATION; DEPRESSION; DIABETES MELLITUS; DIET THERAPY; FUNCTIONAL STATUS; HEALTH CARE DELIVERY; HEALTH LITERACY; HEART REHABILITATION; HOME REHABILITATION; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LOW INCOME COUNTRY; MEDICATION COMPLIANCE; MENTAL HEALTH; MOBILE APPLICATION; MORTALITY; NUTRITIONAL ASSESSMENT; OBESITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT REFERRAL; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; RETURN TO WORK; REVIEW; SECONDARY PREVENTION; SELF CARE; SMOKELESS TOBACCO; SMOKING CESSATION; TOBACCO USE; WITHDRAWAL SYNDROME; CARDIOVASCULAR DISEASES; GLOBAL HEALTH; INTERNATIONAL COOPERATION; ORGANIZATION AND MANAGEMENT; PROCEDURES;

CARDIAC REHABILITATION; CARDIOVASCULAR DISEASES; GLOBAL HEALTH; HUMANS; INTERNATIONAL COOPERATION; SECONDARY PREVENTION;

EID: 84994504384     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2016.08.004     Document Type: Review

References (171)

1. 1. Anderson, L, Oldridge, N, Thompson, DR, Zwisler, AD, Rees, K, Martin, N, et al. Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol 67 (2016), 1–12.
2. 2. Menezes, A, Lavie, C, Milani, R, Forman, D, King, M, Williams, M, Cardiac rehabilitation in the United States. Prog Cardiovasc Dis 56 (2014), 522–529.
3. 3. Menezes, A, Lavie, C, Forman, D, Arena, R, Milani, RV, Franklin, BA, Cardiac rehabilitation in the elderly. Prog Cardiovasc Dis 57 (2014), 152–159.
4. 4. AACVPR, Guidelines for Cardiac Rehabilitation and Secondary Prevention Programs. ed. 5, 2013, Human Kinetics, Champaign, Illinois.
5. 5. Woodruffe, S, Neubeck, L, Clark, RA, Gray, K, Ferry, C, Finan, J, et al. Australian Cardiovascular Health and Rehabilitation Association (ACRA) core components of cardiovascular disease secondary prevention and cardiac rehabilitation 2014. Heart Lung Circ 24 (2015), 430–441.
6. 6. The British Association for Cardiovascular Prevention and Rehabilitation, The BACPR standards and core components for cardiovascular disease prevention and rehabilitation. http://www.bacpr.com/resources/46C_BACPR_Standards_and_Core_Components_2012.pd;, 2012 [accessed 13 Feb 2015].
7. 7. Stone, JA, Arthur, HM, Suskin, N, Canadian Guidelines for Cardiac Rehabilitation and Cardiovascular Disease Prevention: Translating Knowledge into Action. ed. 3, 2009, Canadian Association of Cardiac Rehabilitation, Winnipeg, MB.
8. 8. Piepoli, MF, CorrÃ, U, Adamopoulos, S, Benzer, W, Bjarnason-Wehrens, B, Cupples, M, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery: a policy statement from the Cardiac Rehabilitation Section of the European Association for Cardiovascular Prevention & Rehabilitation. Endorsed by the Committee for Practice Guidelines of the European Society of Cardiology. Eur J Prev Cardiol 21 (2014), 664–681.
9. 9. Cortes-Bergoderi, M, Lopez-Jimenez, F, Herdy, AH, Zeballos, C, Anchique, C, Santibañez, C, et al. Availability and characteristics of cardiovascular rehabilitation programs in South America. J Cardiopulm Rehabil Prev 33 (2013), 33–41.
10. 10. The World Bank, Countries and Lending Groups. http://data.worldbank.org/about/country-classifications [accessed 12 May 2014].
11. 11. World Health Organization, Rehabilitation After Cardiovascular Diseases, with Special Emphasis on Developing Countries: Report of a WHO Committee. 1993, WHO, Geneva.
12. 12. Grace, SL, Turk-Adawi, K, Contractor, A, Atrey, A, Campbell, N, Derman, W, et al. Cardiac rehabilitation delivery model for low-resource settings. Heart, 2016, 10.1136/heartjnl-2015-309209 [heartjnl-2015-309209].
13. 13. Piepoli, MF, Corra, U, Adamopoulos, S, Benzer, W, Bjarnason-Wehrens, B, Cupples, M, et al. Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery. Eur J Prev Cardiol 0 (2012), 1–18.
14. 14. Grace, SL, Warburton, DR, Stone, JA, Sanderson, BK, Oldridge, N, Jones, J, et al. International charter on cardiovascular prevention and rehabilitation: a call for action. J Cardiopulm Rehabil Prev 33 (2013), 128–131.
15. 15. Hancock, K, Davidson, PM, Daly, J, Webber, D, Chang, E, An exploration of the usefulness of motivational interviewing in facilitating secondary prevention gains in cardiac rehabilitation. J Cardiopulm Rehabil Prev 25 (2005), 200–206.
16. 16. Borghi-Silva, A, Mendes, RG, Trimer, R, Cipriano, G Jr, Current trends in reducing cardiovascular disease risk factors from around the world: focus on cardiac rehabilitation in Brazil. Prog Cardiovasc Dis 56 (2014), 536–542.
17. 17. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002), 111–117.
18. 18. Fletcher, GF, Ades, PA, Kligfield, P, Arena, R, Balady, GJ, Bittner, VA, et al. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 128 (2013), 873–934.
19. 19. Mendis, S, Abegunde, D, Yusuf, S, Ebrahim, S, Shaper, G, Ghannem, H, et al. WHO study on prevention of recurrences of myocardial infarction and stroke (WHO-PREMISE). Bull World Health Organ 83 (2005), 820–829.
20. 20. Ferruzzi, M, Coulston, AM, Boushey, CJ, Nutrition in the Prevention and Treatment of Disease (ed 3). 2012, Academic Press, Waltham, MA.
21. 21. Bharathi, AV, Kurpad, AV, Thomas, T, Yusuf, S, Saraswathi, G, Vaz, M, Development of food frequency questionnaires and a nutrient database for the prospective urban and rural epidemiological (PURE) pilot study in South India: methodological issues. Asia Pac J Clin Nutr 17 (2008), 178–185.
22. 22. Dehghan, M, Ilow, R, Zatonska, K, Szuba, A, Zhang, X, Mente, A, et al. Development, reproducibility and validity of the food frequency questionnaire in the Poland arm of the Prospective Urban and Rural Epidemiological (PURE) study. J Hum Nutr Diet 25 (2012), 225–232.
23. 23. World Health Organization, WHO STEPS Instrument (Core and Expanded): the WHO STEPwise Approach to Noncommunicable Disease Risk Factor Surveillance (STEPS). 2000, WHO, Geneva.
24. 24. McCullough, ML, Feskanich, D, Stampfer, MJ, Giovannucci, EL, Rimm, EB, Hu, FB, et al. Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr 76 (2002), 1261–1271.
25. 25. Lichtenstein, AH, Appel, LJ, Brands, M, Carnethon, M, Daniels, S, Franch, HA, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association nutrition committee. Circulation 114 (2006), 82–96.
26. 26. Indian Institute of Population Sciences (IIPS), Global Adult Tobacco Survey India 2009–2010. 2010, Ministry of Health and Family Welfare, Government of India, New Delhi.
27. 27. World Health Organization, Global Adult Tobacco Survey: Bangladesh. Fact Sheet, Summary Report, Bangladesh. http://www.who.int/tobacco/surveillance/global_adult_tobacco_survey_bangladesh_report_2009.pdf, 2009 [accessed 15 Oct 2015].
28. 28. Kotz, D, West, R, Explaining the social gradient in smoking cessation: it's not in the trying, but in the succeeding. Tob Control 18 (2009), 43–46.
29. 29. Vangeli, E, Stapleton, J, Smit, E, Borland, R, West, R, Predictors of attempts to stop smoking and their success in adult general population samples: a systematic review. Addiction 106 (2011), 2110–2121.
30. 30. Heatherton, T, Kozlowski, LT, Fagerström, KO, The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 86 (1991), 1119–1127.
31. 31. Fagerström, K, Time to first cigarette; the best single indicator of tobacco dependence?. Monaldi Arch Chest Dis 59 (2003), 91–94.
32. 32. World Health Organization, Obesity and Overweight: Fact Sheet No. 311. 2014, WHO, Geneva.
33. 33. World Health Organization, Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet 363 (2004), 157–163.
34. 34. World Health Organization, Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation. 2011, WHO, Geneva.
35. 35. Alberti, KGMM, Zimmet, P, Shaw, J, Metabolic syndrome a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 23 (2006), 469–480.
36. 36. French, KS, Transforming nursing care through health literacy ACTS. Nurs Clin North Am 50 (2015), 87–98.
37. 37. Nouri, SS, Rudd, RE, Health literacy in the “oral exchange”: an important element of patient-provider communication. Patient Educ Couns 98 (2015), 565–571.
38. 38. Cranton, P, Planning Instruction for Adult Learners. 1989, Wall and Emerson, Toronto.
39. 39. Scott, J, Thompson, D, Assessing the information needs of post-myocardial infarction patients: a systematic review. Patient Educ Couns 50 (2003), 167–177.
40. 40. Timmins, F, Kaliszer, M, Information needs of myocardial infarction patients. Eur J Cardiovasc Nurs 2 (2003), 57–65.
41. 41. Ghisi, GL, Santos, RZ, Bonin, CB, Roussenq, S, Grace, SL, Oh, P, et al. Validation of a Portuguese version of the Information Needs in Cardiac Rehabilitation (INCR) scale in Brazil. Heart Lung 43 (2014), 192–197.
42. 42. Herridge, ML, Stimler, CE, Southard, DR, King, ML, AACVPR, Task Force, Depression screening in cardiac rehabilitation: AACVPR task force report. J Cardiopulm Rehabil 25 (2005), 11–13.
43. 43. Lichtman, JH, Bigger, JT Jr., Blumenthal, JA, Frasure-Smith, N, Kaufmann, PG, Lespérance, F, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 118 (2008), 1768–1775.
44. 44. Cahill, M, Bilanovic, A, Kelly, S, Bacon, S, Grace, SL, Screening for depression in cardiac rehabilitation: a review. J Cardiopulm Rehabil Prev 35 (2015), 225–230.
45. 45. Bech, P, Clinical Psychometric. 2012, Oxford, UK, John Wiley & Sons Ltd.
46. 46. Mental Health Services, WHO-5 questionnaires. http://www.psykiatri-regionh.dk/who5/menu/WHO-5+Questionnaire/ [accessed 20 Feb 2014].
47. 47. Rosengren, A, Hawken, S, Ounpuu, S, Sliwa, K, Zubaid, M, Almahmeed, WA, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case–control study. Lancet 364 (2004), 953–962.
48. 48. Friedewald, WT, Fredrickson, DS, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972), 499–502.
49. 49. Martin, SS, Blaha, MJ, Elshazly, MB, Brinton, EA, Toth, PP, McEvoy, JW, et al. Friedewald-estimated versus directly measured low-density lipoprotein cholesterol and treatment implications. J Am Coll Cardiol 62 (2013), 732–739.
50. 50. Mora, S, Rifai, N, Buring, JE, Ridker, PM, Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27 331 women. Clin Chem 55 (2009), 888–894.
51. 51. Bansal, S, Buring, JE, Rifai, N, Mora, S, Sacks, FM, Ridker, PM, Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298 (2007), 309–316.
52. 52. Campbell, NRC, Berbari, AE, Cloutier, L, Gelfer, M, Kenerson, JG, Khalsa, TK, et al. Policy statement of the world hypertension league on noninvasive blood pressure measurement devices and blood pressure measurement in the clinical or community setting. J Clin Hypertens (Greenwich) 16 (2014), 320–322.
53. 53. World Health Organization, Affordable Technology: Blood Pressure Measuring Devices for Low Resource Settings. 2005, WHO, Geneva.
54. 54. Gee, ME, Campbell, N, Sarrafzadegan, N, Jafar, T, Khalsa, TK, Mangat, B, et al. Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the world hypertension league expert committee. J Clin Hypertens (Greenwich) 16 (2014), 773–781.
55. 55. Iqbal, R, Anand, S, Ounpuu, S, Islam, S, Zhang, X, Rangarajan, S, et al. Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation 118 (2008), 1929–1937.
56. 56. Yusuf, S, Hawken, S, Ounpuu, S, Dans, T, Avezum, A, Lanas, F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364 (2004), 937–952.
57. 57. Krauss, RM, Eckel, RH, Howard, B, Appel, LJ, Daniels, SR, Deckelbaum, RJ, et al. AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102 (2000), 2284–2299.
58. 58. Popkin, BM, Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases. Am J Clin Nutr 84 (2006), 289–298.
59. 59. DiNicolantonio, J, Lucan, S, O'Keefe, H, The evidence for saturated fat and for sugar related to coronary heart disease. Prog Cardiovasc Dis 58 (2016), 464–472.
60. 60. DiNicolantonio, J., O'Keefe, H., Hypertension due to toxic white crystals in the diet: should we blame salt or sugar?. Prog Cardiovasc Dis 59 (2016), 219–225.
61. 61. O'Keefe, E, DiNicolantonio, J, Patil, H, Helzberg, JH3, Lavie, CJ, Lifestyle choices fuel epidemics of diabetes and cardiovascular disease among Asian Indians. Prog Cardiovasc Dis 58 (2016), 505–513.
62. 62. Kabagambe, EK, Baylin, A, Campos, H, Nonfatal acute myocardial infarction in Costa Rica: modifiable risk factors, population-attributable risks, and adherence to dietary guidelines. Circulation 115 (2007), 1075–1081.
63. 63. Teo, K, Lear, S, Islam, S, Mony, P, Dehghan, M, Li, W, et al. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low-income countries: the Prospective Urban Rural Epidemiology (PURE) study. JAMA 309 (2013), 1613–1621.
64. 64. Wood, DA, Kotseva, K, Connolly, S, Jennings, C, Mead, A, Jones, J, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. Lancet 371 (2008), 1999–2012.
65. 65. Giannuzzi, P, Temporelli, PL, Marchioli, R, Maggioni, AP, Balestroni, G, Ceci, V, et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian cardiac rehabilitation network. Arch Intern Med 168 (2008), 2194–2204.
66. 66. Estruch, R, Ros, E, Salas-Salvadó, J, Covas, MI, Corella, D, Arós, F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 368 (2013), 1279–1290.
67. 67. Hu, FB, Willett, WC, Optimal diets for prevention of coronary heart disease. JAMA 288 (2002), 2569–2578.
68. 68. World Health Organization, Interventions on Diet and Physical Activity: What Works. 2009, WHO, Geneva.
69. 69. Buller, DB, Morrill, C, Taren, D, Aickin, M, Sennott-Miller, L, Buller, MK, et al. Randomized trial testing the effect of peer education at increasing fruit and vegetable intake. J Natl Cancer Inst 91 (1999), 1491–1500.
70. 70. Mendis, S, Puska, P, Norrving, B, Global Atlas on Cardiovascular Disease Prevention and Control. 2011, WHO, Geneva.
71. 71. Perez-Stable, E, Viswanath, K, Fagan, P, Vallone, D, Buchting, FO, Global tobacco inequalities: a new frontier. Cancer Causes Control 23 (2012), 1–5.
72. 72. Sarkar, BK, Reddy, KS, Priorities for tobacco control research in India. Addiction 107 (2012), 2066–2068.
73. 73. Stead, LF, Bergson, G, Lancaster, T, Physician advice for smoking cessation. Cochrane Database Syst Rev, 2, 2008, CD000165, 10.1002/14651858.CD000165.pub3.
74. 74. Lemmens, V, Oenema, A, Knut, IK, Brug, J, Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev 17 (2008), 535–544.
75. 75. Stead, LF, Hartmann-Boyce, J, Perera, R, Lancaster, T, Telephone counselling for smoking cessation. Cochrane Database Syst Rev, 8, 2013, CD002850, 10.1002/14651858.CD002850.pub3.
76. 76. Rice, VH, Hartmann-Boyce, J, Stead, LF, Nursing interventions for smoking cessation. Cochrane Database Syst Rev, 8, 2013, CD001188, 10.1002/14651858.CD001188.pub4.
77. 77. Lancaster, T, Stead, LF, Self help interventions for smoking cessation. Cochrane Database Syst Rev, 2, 2005, CD001118.
78. 78. Stead, LF, Lancaster, T, Group behaviour therapy programmes for smoking cessation. Cochrane Database Syst Rev, 2, 2005, CD001007.
79. 79. Hartmann-Boyce, J, Stead, LF, Cahill, K, Lancaster, T, Efficacy of interventions to combat tobacco addiction: Cochrane update of 2012 reviews. Addiction 108 (2013), 1711–1721.
80. 80. Whittaker, R, McRobbie, H, Bullen, C, Borland, R, Rodgers, A, Gu, Y, Mobile phone-based interventions for smoking cessation. Cochrane Database of Syst Rev, 2012, CD006611, 10.1002/14651858.CD006611.pub3.
81. 81. Stead, L, Perera, R, Bullen, C, Mant, D, Hartmann-Boyce, J, Cahill, K, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev, 11, 2012, CD000146, 10.1002/14651858.
82. 82. Cahill, K, Stevens, S, Perera, R, Lancaster, T, Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev, 5, 2013, CD009329.
83. 83. Hajek, P, McRobbie, H, Myers, K, Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis. Thorax 68 (2013), 1037–1042.
84. 84. Stead, L, Lancaster, T, Combined pharmacotherapy and behavioural interventions for smoking cessation (review). Cochrane Database Syst Rev, 10, 2012, CD008286, 10.1002/14651858.CD008286.pub2.
85. 85. World Health Organization, WHO CVD-Risk Management Package for Low- and Medium-Resource Settings. 2002, WHO, Geneva.
86. 86. McEwen, A, Hajek, P, McRobbie, H, West, R, The Manual of Smoking Cessation: a Guide for Counsellors and Practitioners. 2006, Blackwell Publishing Ltd, Oxford, UK.
87. 87. Ahluwalia, JS, Harris, K, Catley, D, Okuyemi, KS, Mayo, MS, Sustained-release bupropion for smoking cessation in African Americans: a randomized controlled trial. JAMA 288 (2002), 468–474.
88. 88. Kumar, R, Kushwaha, AS, Mahakud, GC, Okuyemi, KS, Mayo, MS, et al. Smoking cessation interventions and continuous abstinence rate at one year. Indian J Chest Dis Allied Sci 49 (2007), 201–207.
89. 89. Jain, R, Jhanjee, S, Jain, V, Gupta, T, Mittal, S, Goelz, P, et al. A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India. Nicotine Tob Res 16 (2014), 50–57.
90. 90. West, R, Zatonski, W, Cedzynska, M, Lewandowska, D, Pazik, J, Aveyard, P, et al. Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med 365 (2011), 1193–1200.
91. 91. West, R, McNeill, A, Raw, M, Verifiable CPD paper: smokeless tobacco cessation guidelines for health professionals in England. Br Dent J 196 (2004), 611–618.
92. 92. Ebbert, J, Montori, VM, Erwin, PJ, Stead, LF, Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev, 2, 2011, CD004306, 10.1002/14651858.CD004306.pub4.
93. 93. Lavie, CJ, De Schutter, A, Parto, P, Jahangir, E, Kokkinos, P, Ortega, FB, et al. Obesity and prevalence of cardiovascular diseases and prognosis—the obesity paradox updated. Prog Cardiovasc Dis 58 (2016), 537–547.
94. 94. Cooney, M, Reiner, Z, Sheu, W, Ryden, L, Sutter, Jd, De Bacquer, D, et al. SURF— survey of risk factor management: first report of an international audit. Eur J Prev Cardiol 21 (2014), 813–822.
95. 95. Liu, L, Ma, J, Yin, X, Kelepouris, E, Eisen, HJ, Global variability in angina pectoris and its association with body mass index and poverty. Am J Cardiol 107 (2011), 655–661.
96. 96. Chen, Y, Copeland, WK, Vedanthan, R, Grant, E, Lee, JE, Gu, D, et al. Association between body mass index and cardiovascular disease mortality in East Asians and South Asians: pooled analysis of prospective data from the Asia cohort consortium. BMJ, 347, 2013, f5446, 10.1136/bmj.f5446.
97. 97. Lanas, F, Avezum, A, Bautista, LE, Diaz, R, Luna, M, Islam, S, et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 115 (2007), 1067–1074.
98. 98. World Health Organization, Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013–2020. 2013, WHO, Geneva.
99. 99. Jensen, MD, Ryan, DH, Apovian, CM, Ard, JD, Comuzzie, AG, Donato, KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Obesity Society. J Am Coll Cardiol 63 (2014), 2985–3023.
100. 100. Michaud, PC, Goldman, DP, Lakdawalla, DN, Zheng, Y, Gailey, AH, The value of medical and pharmaceutical interventions for reducing obesity. J Health Econ 31 (2012), 630–643.
101. 101. Pogosova, N, Saner, H, Pedersen, SS, Cupples, ME, McGee, H, Höfer, S, et al. Psychosocial aspects in cardiac rehabilitation: from theory to practice a position paper from the cardiac rehabilitation section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol 22 (2015), 1290–1306.
102. 102. Lichtman, JH, Froelicher, ES, Blumenthal, JA, Carney, RM, Doering, LV, Frasure-Smith, N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation, 2014, 10.1161/CIR.0000000000000019.
103. 103. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders. 5 ed., 2013, American Psychiatric Publishing, Arlington, VA.
104. 104. Thombs, BD, Roseman, M, Coyne, JC, de Jonge, P, Delisle, VC, Arthurs, E, et al. Does evidence support the American Heart Association's recommendation to screen patients for depression in cardiovascular care? An updated systematic review. PLoS One, 8, 2013, e52654, 10.1371/journal.pone.0052654.
105. 105. Horton, R, GBD 2010: understanding disease, injury, and risk. Lancet 380 (2012), 2053–2054.
106. 106. Barefoot, JC, Helms, MJ, Mark, DB, Blumenthal, JA, Califf, RM, Haney, TL, et al. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol 78 (1996), 613–617.
107. 107. McGrady, A, McGinnis, R, Badenhop, D, Bentle, M, Rajput, M, Effects of depression and anxiety on adherence to cardiac rehabilitation. J Cardiopulm Rehabil Prev 29 (2009), 358–364.
108. 108. Glassman, AH, O'Connor, CM, Califf, RM, Swedberg, K, Schwartz, P, Bigger, JT Jr, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288 (2002), 701–709.
109. 109. Enrichd WCft, Investigators, Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial. JAMA 289 (2003), 3106–3116.
110. 110. Rutledge, T, Redwine, LS, Linke, SE, Mills, PJ, A meta-analysis of mental health treatments and cardiac rehabilitation for improving clinical outcomes and depression among patients with coronary heart disease. Psychosom Med 75 (2013), 335–349.
111. 111. Critchley, J, Liu, J, Zhao, D, Wei, W, Capewell, S, Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 110 (2004), 1236–1244.
112. 112. Rastam, S, AL Ali, R, Maziak, W, Mzayek, F, Fouad, FM, O'Flaherty, M, et al. Explaining the increase in coronary heart disease mortality in Syria between 1996 and 2006. BMC Public Health, 12, 2012, 754, 10.1186/1471-2458-12-754.
113. 113. Cholesterol Treatment Trialists Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet 376 (2010), 1670–1681.
114. 114. Lopez-Jimenez, F, Simha, V, Thomas, RJ, Allison, TG, Basu, A, Fernandes, R, et al. A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps. Mayo Clin Proc 89 (2014), 1257–1278.
115. 115. Expert Panel, Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). 2002, Bethesda, MD, NHLBI.
116. 116. Chen, Z, Chen, J, Collins, R, Guo, Y, Peto, R, Wu, F, et al. China Kadoorie Biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol 40 (2011), 1652–1666.
117. 117. Nieuwlaat, R, Wilczynski, N, Navarro, T, Hobson, N, Jeffery, R, Keepanasseril, A, et al. Interventions for enhancing medication adherence. Cochrane Database of Syst Rev, 11, 2014, CD000011, 10.1002/14651858.CD000011.pub4.
118. 118. Sanz, G, Fuster, V, Polypill and global cardiovascular health strategies. Semin Thorac Cardiovasc Surg 23 (2011), 24–29.
119. 119. Lim, L, Haq, N, Mahmood, S, Hoeksema, L, ACPM Prevention Practice Committee, American College of Preventive Medicine. Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine position statement on preventive practice. Am J Prev Med 40 (2011), e1–e10.
120. 120. World Health Organization, A Global Brief on Hypertension: Silent Killer, Global Public Health Crisis World Health Day 2013. 2013, WHO, Geneva.
121. 121. Dasgupta, K, Quinn, RR, Zarnke, KB, Rabi, DM, Ravani, P, Daskalopoulou, SS, et al. The 2014 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 30 (2014), 485–501.
122. 122. Lopez-Jimenez, F, Kramer, VC, Masters, B, Stuart, PM, Mullooly, C, Hinshaw, L, et al. Recommendations for managing patients with diabetes mellitus in cardiopulmonary rehabilitation: an American association of cardiovascular and pulmonary rehabilitation statement. J Cardiopulm Rehabil Prev 32 (2012), 101–112.
123. 123. Ghisi, GL, Abdallah, F, Grace, SL, Thomas, S, Oh, P, A systematic review of patient education in cardiac patients: do they increase knowledge and promote health behavior change?. Patient Educ Couns 95 (2014), 160–174.
124. 124. Aldcroft, SA, Taylor, NF, Blackstock, FC, O'Halloran, PD, Psychoeducational rehabilitation for health behavior change in coronary artery disease: a systematic review of controlled trials. J Cardiopulm Rehabil Prev 31 (2011), 273–281.
125. 125. Brown, JPR, Clark, AM, Dalal, H, Welch, K, Taylor, RS, Effect of patient education in the management of coronary heart disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Prev Cardiol 20 (2013), 701–714.
126. 126. Irmak, Z, Fesci, H, Effects of nurse-managed secondary prevention program on lifestyle and risk factors of patients who had experienced myocardial infarction. Appl Nurs Res 23 (2010), 147–152.
127. 127. Doak, CC, Doak, LG, Root, JH, Teaching Patients with Low Literacy Skills. ed. 2, 2007, JB Lippincott, Philadelphia, Pennsylvania.
128. 128. Schwarzer, R, Self-Efficacy in the Adoption and Maintenance of Health Behaviors: Theoretical Approaches and a New Model. Schwarzer, R, (eds.) Self-Efficacy: Thought Control of Action, 1992, Hemisphere, Washington, DC, 217–242.
129. 129. Bandura, A, Social Foundations of Thought and Action: a Social Cognitive Theory. 1986, Englewood Cliffs, New Jersey, Prentice-Hall.
130. 130. Knowles, MS, The Modern Practice of Adult Education. 1980, Association Press, New York.
131. 131. Haskell, WL, Alderman, EL, Fair, JM, Maron, DJ, Mackey, SF, Superko, HR, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease. The Stanford Coronary Risk Intervention Project (SCRIP). Circulation 89 (1994), 975–990.
132. 132. DeBusk, RF, Miller, NH, Superko, HR, Dennis, CA, Thomas, RJ, Lew, HT, et al. A case-management system for coronary risk factor modification after acute myocardial infarction. Ann Intern Med 120 (1994), 721–729.
133. 133. Berra, K, Miller, NH, Jennings, C, Nurse-based models for cardiovascular disease prevention: from research to clinical practice. J Cardiovasc Nurs 26 (2011), S46–S55.
134. 134. Kovoor, P, Lee, AKY, Carrozzi, F, Wiseman, V, Byth, K, Zecchin, R, et al. Return to full normal activities including work at two weeks after acute myocardial infarction. Am J Cardiol 97 (2006), 952–958.
135. 135. Hall, R, Joseph, D, Schwartz-Barcott, D, Behavioral maintenance: a closer look. Nurs Forum 37 (2002), 5–11.
136. 136. American College of Sports Medicine, Balady, G, ACSM's Guidelines for Exercise Testing and Prescription. ed. 6, 2000, Lippincott Williams and Wilkins, Philadelphia, Pennsylvania.
137. 137. Isaaz, K, Coudrot, M, Sabry, MH, Cerisier, A, Lamaud, M, Robin, C, et al. Return to work after acute ST-segment elevation myocardial infarction in the modern era of reperfusion by direct percutaneous coronary intervention. Arch Cardiovasc Dis 103 (2010), 310–316.
138. 138. Buckley, JP, Furze, G, Doherty, P, Speck, L, Connolly, S, Hinton, S, et al. BACPR scientific statement: British standards and core components for cardiovascular disease prevention and rehabilitation. Heart 99 (2013), 1069–1071.
139. 139. Myers, J, Prakash, M, Froelicher, V, Do, D, Partington, S, Atwood, JE, Exercise capacity and mortality among men referred for exercise testing. NEJM 346 (2002), 793–801.
140. 140. Bravata, DM, Smith-Spangler, C, Sundaram, V, Gienger, AL, Lin, N, Lewis, R, et al. Using pedometers to increase physical activity and improve health: a systematic review. JAMA 298 (2007), 2296–2304.
141. 141. Ghisi, GL, Durieux, A, Manfroi, WC, Herdy, AH, Carvalho, Td, Andrade, A, et al. Construction and validation of the CADE-Q for patient education in cardiac rehabilitation programs. Arq Bras Cardiol 94 (2010), 813–822.
142. 142. Ghisi, GL, Grace, SL, Thomas, S, Evans, MF, Oh, P, Development and psychometric validation of the second version of the coronary artery disease education questionnaire (CADE-Q II). Patient Educ Couns 98 (2015), 378–383.
143. 143. Bech, P, Measuring the dimension of psychological general well-being by the WHO-5. Qual Life Newsl 32 (2004), 15–16.
144. 144. Rosendorff, C, Lackland, DT, Allison, M, Aronow, WS, Black, HR, Blumenthal, RS, et al. Treatment of hypertension in patients with coronary artery disease: a scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension. J Am Coll Cardiol 65 (2015), 1998–2038.
145. 145. Morisky, DE, Green, LW, Levine, DM, Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 24 (1986), 67–74.
146. 146. Grace, SL, Poirier, P, Norris, CM, Oakes, GH, Somanader, DS, Suskin, N, et al. Pan-Canadian development of cardiac rehabilitation and secondary prevention quality indicators. Can J Cardiol 30 (2014), 945–948.
147. 147. Grace, SL, Bennetta, S, Ardern, C, Clark, AM, Cardiac rehabilitation series: Canada. Prog Cardiovasc Dis 56 (2014), 530–535.
148. 148. Redfern, J, Maiorana, A, Neubeck, L, Clark, AM, Briffa, T, Achieving coordinated secondary prevention of coronary heart disease for all in need (SPAN). Int J Cardiol 146 (2011), 1–3.
149. 149. Sjöström-Strand, A, Ivarsson, B, Sjöberg, T, Primary health care resources for rehabilitation and secondary prevention after myocardial infarction — a questionnaire survey. Scand J Caring Sci 27 (2013), 260–266.
150. 150. Dalal, HM, Zawada, A, Jolly, K, Moxham, T, Taylor, RS, Home based versus centre based cardiac rehabilitation: Cochrane systematic review and meta-analysis. BMJ, 340, 2010, 10.1136/bmj.b5631.
151. 151. Humphrey, R, Guazzi, M, Niebauer, J, Cardiac rehabilitation in Europe. Prog Cardiovasc Dis 56 (2014), 551–556.
152. 152. Clark, RA, Conway, A, Poulsen, V, Keech, W, Tirimacco, R, Tideman, P, Alternative models of cardiac rehabilitation: a systematic review. Eur J Prev Cardiol 22 (2015), 35–74.
153. 153. Mosleh, SM, Bond, CM, Lee, AJ, Kiger, A, Campbell, NC, Effects of community based cardiac rehabilitation: comparison with a hospital-based programme. Eur J Cardiovasc Nurs 14 (2015), 108–116.
154. 154. Centre for Disease Control Research and Development NHRD Ministry of Health Republic of Indonesia in Collaboration with World Health Organization: Monitoring and Evaluation of the Integrated Community-Based Intervation for the Prevention of Noncummunicable Diseases in Depok, West Java, Indonesia. 2006, MOH, Jakarta.
155. 155. Radi, B, S36-3 cardiac rehabilitation in Indonesia. Glob Heart, 4, 2009, S49.
156. 156. Madan, K, Babu, AS, Contractor, A, Sawhney, JP, Prabhakaran, D, Gupta, R, Cardiac rehabilitation in India. Prog Cardiovasc Dis 56 (2014), 543–550.
157. 157. Singapore Heart Foundation, The SHF heart wellness Centre. http://www.myheart.org.sg/article/cardiac-rehabilitation-and-heart-wellness/shf-isetan-foundation-heart-wellness-centre/about-us/27 [accessed 12 May 2014].
158. 158. Tay, H, Kwan, Y, Ong, K, Chang, JY, Heart wellness programme—a community based cardiac rehabilitation and primary prevention programme to reduce cardiovascular disease in a multi-ethnic society. Ann Acad Med, 42(Suppl. 9), 2013.
159. 159. Rajendran, A, Manoj, S, Karthikeyan, D, Davis, S, Cardiac rehabilitation for CABG patients in south Indian setup: a prospective study. IJPMR 15 (2004), 23–33.
160. 160. Poortaghi, S, Baghernia, A, Golzari, SEJ, Safayian, A, Atri, SB, The effect of home-based cardiac rehabilitation program on self efficacy of patients referred to cardiac rehabilitation center. BMC Res Notes, 6, 2013, 287, 10.1186/1756-0500-6-287.
161. 161. Salvetti, XM, Oliveira, JA, Servantes, DM, Vincenzo de Paola, AA, How much do the benefits cost? Effects of a home-based training programme on cardiovascular fitness, quality of life, programme cost and adherence for patients with coronary disease. Clin Rehabil 22 (2008), 987–996.
162. 162. Wang, W, Chair, SY, Thompson, DR, Twinn, SF, Effects of home-based rehabilitation on health-related quality of life and psychological status in Chinese patients recovering from acute myocardial infarction. Heart Lung 41 (2012), 15–25.
163. 163. Beatty, AL, Fukuoka, Y, Whooley, MA, Using mobile technology for cardiac rehabilitation: a review and framework for development and evaluation. J Am Heart Assoc, 2, 2013, e000568, 10.1161/JAHA.113.000568.
164. 164. Varnfield, M, Karunanithi, M, Lee, CK, Honeyman, E, Arnold, D, Ding, H, et al. Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial. Heart 100 (2014), 1770–1779.
165. 165. Alsaleh, E, Blake, H, Windle, R, Behavioural intervention to increase physical activity among patients with coronary heart disease: protocol for a randomised controlled trial. Int J Nurs Stud 49 (2012), 1489–1493.
166. 166. Källander, K, Tibenderana, JK, Akpogheneta, OJ, Strachan, DL, Hill, Z, ten Asbroek, AH, et al. Mobile health (mHealth) approaches and lessons for increased performance and retention of community health workers in low- and middle-income countries: a review. J Med Internet Res, 15, 2013, e17, 10.2196/jmir.2130.
167. 167. ITU, ITU: Statshot. http://www.itu.int/en/ITU-D/Statistics/Pages/stat/default.aspx, 2014 [accessed 12 May 2014].
168. 168. Pop-Eleches, C, Thirumurthy, H, Habyarimana, JP, Zivin, JG, Goldstein, MP, de Walque, D, et al. Mobile phone technologies improve adherence to antiretroviral treatment in a resource-limited setting: a randomized controlled trial of text message reminders. AIDS 25 (2011), 825–834.
169. 169. Maddison, R, Pfaeffli, L, Whittaker, R, Stewart, R, Kerr, A, Jiang, Y, et al. A mobile phone intervention increases physical activity in people with cardiovascular disease: results from the HEART randomized controlled trial. Eur J Prev Cardiol 22 (2015), 701–709.
170. 170. Esterson, YB, Carey, M, Piette, JD, Thomas, N, Hawkins, M, A systematic review of innovative diabetes care models in low-and middle-income countries (LMICs). J Health Care Poor Underserved 25 (2014), 72–93.
171. 171. World Health Organization, Prevention and Control of Noncommunicable Diseases: Guidelines for Primary Health Care in Low Resource Settings. 2012, WHO, Geneva.